Dr. Lal PathLabs Limited (LALPATHLAB.NS)

INR 3018.6

(-0.67%)

EBITDA Summary of Dr. Lal PathLabs Limited

Dr. Lal PathLabs Limited's latest annual EBITDA in 2023 was 6.78 Billion INR , up 14.62% from previous year.
Dr. Lal PathLabs Limited's latest quarterly EBITDA in 2024 Q2 was 2.24 Billion INR , up 17.73% from previous quarter.
Dr. Lal PathLabs Limited reported an annual EBITDA of 5.31 Billion INR in 2022, down -12.78% from previous year.
Dr. Lal PathLabs Limited reported an annual EBITDA of 6.13 Billion INR in 2021, up 26.26% from previous year.
Dr. Lal PathLabs Limited reported a quarterly EBITDA of 1.7 Billion INR for 2024 Q1, up 16.86% from previous quarter.
Dr. Lal PathLabs Limited reported a quarterly EBITDA of 1.6 Billion INR for 2023 Q1, up 23.73% from previous quarter.

Annual EBITDA Chart of Dr. Lal PathLabs Limited (2023 - 2010)

Historical Annual EBITDA of Dr. Lal PathLabs Limited (2023 - 2010)

Year	EBITDA	EBITDA Growth
2023	6.78 Billion INR	14.62%
2022	5.31 Billion INR	-12.78%
2021	6.13 Billion INR	26.26%
2020	4.87 Billion INR	22.05%
2019	3.98 Billion INR	16.0%
2018	3.38 Billion INR	14.22%
2017	2.94 Billion INR	13.89%
2016	2.64 Billion INR	14.13%
2015	2.29 Billion INR	36.01%
2014	1.68 Billion INR	13.81%
2013	1.46 Billion INR	45.91%
2012	1 Billion INR	13.39%
2011	886.55 Million INR	49.54%
2010	591.02 Million INR	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	2.24 Billion INR	17.73%
2024 Q1	1.7 Billion INR	16.86%
2023 Q1	1.6 Billion INR	23.73%
2023 FY	- INR	14.62%
2023 Q3	1.58 Billion INR	-18.89%
2023 Q4	1.44 Billion INR	-8.94%
2023 Q2	1.95 Billion INR	21.98%
2022 Q3	1.23 Billion INR	-19.02%
2022 Q1	1.25 Billion INR	-5.53%
2022 FY	- INR	-12.78%
2022 Q4	1.29 Billion INR	5.1%
2022 Q2	1.52 Billion INR	21.22%
2021 Q2	1.55 Billion INR	-23.29%
2021 FY	- INR	26.26%
2021 Q3	1.21 Billion INR	-22.14%
2021 Q1	2.03 Billion INR	49.88%
2021 Q4	1.33 Billion INR	9.79%
2020 Q2	1.4 Billion INR	134.67%
2020 Q4	1.35 Billion INR	-11.02%
2020 FY	- INR	22.05%
2020 Q1	597 Million INR	-13.88%
2020 Q3	1.52 Billion INR	8.71%
2019 FY	- INR	16.0%
2019 Q4	693.25 Million INR	-27.86%
2019 Q3	961 Million INR	-22.31%
2019 Q2	1.23 Billion INR	12.97%
2019 Q1	1.09 Billion INR	37.38%
2018 Q4	797.07 Million INR	2.45%
2018 Q3	778 Million INR	-20.37%
2018 Q2	977 Million INR	15.76%
2018 Q1	844 Million INR	15.78%
2018 FY	- INR	14.22%
2017 Q2	856 Million INR	17.26%
2017 Q4	729 Million INR	14.44%
2017 FY	- INR	13.89%
2017 Q3	637 Million INR	-25.58%
2017 Q1	730 Million INR	31.56%
2016 Q4	554.9 Million INR	3.37%
2016 FY	- INR	14.13%
2016 Q3	536.8 Million INR	-37.65%
2016 Q2	860.9 Million INR	29.63%
2016 Q1	664.1 Million INR	10.11%
2015 Q4	603.1 Million INR	-19.03%
2015 FY	- INR	36.01%
2015 Q1	533.2 Million INR	11.44%
2015 Q2	413.9 Million INR	-22.37%
2015 Q3	744.8 Million INR	79.95%
2014 Q3	414.8 Million INR	0.0%
2014 FY	- INR	13.81%
2014 Q4	478.47 Million INR	15.35%
2013 FY	- INR	45.91%
2012 FY	- INR	13.39%
2011 FY	- INR	49.54%
2010 FY	- INR	0.0%

Peer EBITDA Comparison of Dr. Lal PathLabs Limited

Name	EBITDA	EBITDA Difference
Krsnaa Diagnostics Limited	1.61 Billion INR	-321.099%
Metropolis Healthcare Limited	2.96 Billion INR	-128.338%
Thyrocare Technologies Limited	1.48 Billion INR	-357.805%
Vijaya Diagnostic Centre Limited	2.2 Billion INR	-206.994%
Vimta Labs Limited	878.1 Million INR	-672.288%